The diagnosis of NMDAR relies heavily on the detection of the NMDA-related autoantibodies (Ryan 159). The treatment of this disease can be frustrating since there is no established standard of care, being that NMDAR is still relatively new. There is also clashing data in the literature that makes one method of treatment difficult to spread to doctors (Mann). This actually creates a unique problem related to treatment which involves access to care, revealing broad difficulties with processing new medical
The diagnosis of NMDAR relies heavily on the detection of the NMDA-related autoantibodies (Ryan 159). The treatment of this disease can be frustrating since there is no established standard of care, being that NMDAR is still relatively new. There is also clashing data in the literature that makes one method of treatment difficult to spread to doctors (Mann). This actually creates a unique problem related to treatment which involves access to care, revealing broad difficulties with processing new medical